Investor Overview

Our Investor Information

Company Overview

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Annual Report
Press Releases
April 7, 2021
Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference
March 20, 2021
Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued Weight Loss at Up to Nine Months in Patients with HET Obesity on Setmelanotide at ENDO 2021
Upcoming Events
April 14, 2021 at 11:45 AM EDT
20th Annual Needham Virtual Healthcare Conference
Investor FAQs
More FAQs are coming soon.

Founded

Delaware, November 2008

Headquarters

222 Berkeley Street, 12th Floor
Boston, MA 02116

CUSIP number

76243J105

Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120